San Diego, CA, United States of America

Tie Lin Wang

This inventor holds 1 USPTO granted patent. Top assignee: Exelixis Patent Company LLC. Active years: 2014.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Tie Lin Wang. Retrieved from https://idiyas.com/inventor/tie-lin-wang-aad8likf

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 11.0

ph-index = 1

Forward Citations = 9(Granted Patents)


Company Filing History:


Years Active: 2014

Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovations of Tie Lin Wang

Introduction

Tie Lin Wang is a notable inventor based in San Diego, California. He has made significant contributions to the field of pharmaceutical sciences, particularly in the modulation of liver X receptors. His work has implications for various therapeutic applications.

Latest Patents

Tie Lin Wang holds a patent for "Modulators of LXR." This patent includes compounds of the invention, such as compounds of Formulae Ia, Ib, Ic, or Id, along with pharmaceutically acceptable salts, isomers, and prodrugs thereof. These compounds are useful as modulators of the activity of liver X receptors. The patent also discloses pharmaceutical compositions containing these compounds and methods of using them.

Career Highlights

He is currently associated with Exelixis Patent Company LLC, where he continues to innovate in the pharmaceutical sector. His work has led to advancements in drug development and therapeutic strategies.

Collaborations

Tie Lin Wang collaborates with notable colleagues, including Brett Bradley Busch and Brenton Todd Flatt. Their combined expertise contributes to the success of their projects and innovations.

Conclusion

Tie Lin Wang's contributions to the field of pharmaceutical sciences through his patent on liver X receptor modulators highlight his role as an influential inventor. His work continues to pave the way for future innovations in drug development.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…